OvationLab
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, OvationLab sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
OvationLab: 6 sponsored US clinical trials, 4 recruiting.
OvationLab sponsors 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Biofilm, with 1 trials.
Upper-quartile sponsor footprint
OvationLab sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
NCT07579845
Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry
NCT07605078
Effects of Biocidin on Oral Biofilms
NCT07408245
Terraflora Daily Care and Gastrointestinal Health
NCT07355634
Beta Glucan 500 and Biological Age and Immune Age
NCT07104929
Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations
NCT06640465
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the OvationLab pipeline
4 recruiting of 6 indexed (67% open); 2 completed (33%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Biofilm (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
OvationLab: open-pipeline peers nationwide
Peers matched on 6 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
OvationLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
- Alexander B Olawaiye, MD · 67% recruiting · 3 trials
Related
What to do with this OvationLab page
6 registered trials is a research-attention snapshot, not an endorsement of OvationLab or any single study.
- 4 of OvationLab's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Biofilm is the condition OvationLab studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Biofilm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
OvationLab pipeline card: 6 registered trials from official public datasets.Report a data error.